Nifedipine Tablet, Extended Release
Product Images NDC 51655-798

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 51655-798). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 798 26 Master Bottle Label Approval Rev A 02 22)

Nifedipine Extended-Release Tablets, USP 30 mg package label for 90 tablets by Northwind Health Company, LLC. The label includes dosing instructions to refer to the package insert and storage conditions between 15°C and 30°C (59°F–86°F). It states that the product is Rx only and has additional handling advisories to keep out of reach of children and protect from moisture and light.*

FDA Label Image

Nifedipine Chemical Structure (Nifedipine 01)

Chemical structure of nifedipine, showing a dihydropyridine ring with nitro and acetyl functional groups and a phenyl ring attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.